Perspectives on the n-methyl-d-aspartate/nitric oxide cascade and opioid tolerance

Neuropsychopharmacology

Volumn 13, Issue 4, 1995, Pages 309-313

  Pasternak, Gavril W ^a   Kolesnikov, Yuri A ^a   Babey, Anna Marie ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Analgesia; Dependence; Methylene blue; Nitric oxide; NMDA; Opioid receptor; Opioids; Tolerance; Withdrawal

Indexed keywords

2 AMINO 4,5 (1,2 CYCLOHEXYL) 7 PHOSPHONOHEPTANOIC ACID; ARGININE; METHYLENE BLUE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; OPIATE;

ANALGESIA; ANIMAL EXPERIMENT; DRUG TOLERANCE; MOUSE; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ARGININE; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; MORPHINE; NARCOTICS; NITRIC OXIDE SYNTHASE; NITROARGININE; OPIOID-RELATED DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0029618055     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00084-Q     Document Type: Review

References (24)

1. Adams ML, Kalicki JM, Meyer ER, Cicero TJ (1993): Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester. Life Sci 52:245-249
2. Babey AM, Kolesnikov Y, Cheng J, Inturrisi CE, Trifilletti RR, Pasternak GW (1994): Nitric oxide and opioid tolerance. Neuropharmacology 33:1463-1470
3. Ben-Eliyahu S, Marek P, Vaccarino AL, Mogil JS, Sternberg WF, Liebeskind JC (1992): The NMDA receptor antagonist MK-801 prevents long-lasting nonassociative morphine tolerance in the rat. Brain Res 575:304-308
4. Bilsky EF, Bernstein N, Pasternak GW, Hruby VJ, Patel D, Porreca F, Lai J (1994): Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spina], administration of an antisense oligodeoxyunucleo-tide to an opioid delta receptor. Life Sci 57:PL79-84
5. Bredt DS, Snyder SH (1992): Nitric oxide, a novel neuronal messenger. Neuron 8:3-11
6. Chien CC, Brown G, Pan YX, Pasternak GW (1994): Blockade of U50, 488H analgesia by antisense oligodeox-ynucleotides to a kappa opioid receptor. Eur J Pharmacol, 253-.R7-8
7. Elliot K, Minami N, Kolesnikov Y, Pasternak GW, Inturrisi CE (1994): The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, Nc-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 56:69-75
8. Kimes AS, Vaupel DB, London ED (1993): Attenuation of some signs of opioid withdrawal by inhibitors of nitric oxide synthase. Psychopharmacology (Berl) 112:521-524
9. Kolesnikov YA, Ferkany J, Pasternak GW (1993): Blockade of mu and kappai opioid analgesic tolerance by NPC17742, a novel NMDA antagonist. Life Sci 53:1489-1494
10. Kolesnikov Y, Maccechini ML, Pasternak GW (1994): 1-Ami-nocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci 55:1393-1398
11. Kolesnikov YA, Pick CG, Pasternak GW (1992): NG-Nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol 221:399-400
12. Kolesnikov Y A, Pick CG, Ciszewska G, Pasternak GW (1993): Blockade of tolerance to morphine but not to k opioids by a nitric oxide synthase inhibitor. Proc Natl Acad Sci USA 90:5162-5166
13. Marek P, Ben-Eliyahu S, Vaccarino AL, Liebeskind JC (1991): Delayed application of MK-801 attenuates development of morphine tolerance in rats. Brain Res 558:163-165.
14. Pan YX, Cheng J, Xi J, Brooks AI, Standifer KM, Pasternak GW (1994): Cloning and expression of a kappa3-related opioid receptor. Regul Pep 54:217-218
15. Pan YX, Cheng J, Xu J, Rossi G, Jacobson E, Ryan-Moro J, Brooks AI, Dean GE, Standifer KM, Pasternak GW (1995): Cloning and functional characterization of a kappa;-related opioid receptor. Mol Pharmacol 47:1180-1188
16. Pasternak G (1993): Phamacologic mechanisms of opioid analgesics. Clin Neuropharmacol 16:1-18
17. Rossi G, Pan YX, Cheng, J, Pasternak GW (1994): Blockade of morphine analgesia by an antisense oligodeoxynucleo-tide against the mu receptor. Life Sci 54:PL375-379
18. Smith AP, Law PY, Loh HH (1988): Role of opioid receptors in narcotic tolerance/dependence. In Pasternak GW (ed), The Opiate Receptors. Clifton, N], Humana, pp 441-488
19. Standifer KM, Chien CC, Wahlestedt C, Brown GP, Pasternak GW (1994): Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor. Neuron 12:805-810
20. Thorat SN, Reddy PL, Bhargava HN (1993): Evidence for the role of nitric oxide in kappa-opiate tolerance in mice. Brain Res 621:171-174
21. Tiseo PJ, Cheng J, Pasternak GW, Inturrisi CE (1994): Modulation of morphine tolerance by the competitive NMDA receptor antagonist LY274614: Assessment of opioid receptor changes. J Pharmacol Exp Ther 268:195-201
22. Tiseo P, Inturrisi CE (1993): Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614. J Pharmacol Exp Ther 264:1090-1096
23. Trujillo KA, Akil H (1991): Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251:85-87
24. Uhl GR, Childers SR, Pasternak GW (1994): An opiate receptor gene family reunion. Trends Neurosci 17:89-93